24/7 Customer Support
Viral vectors & plasmid DNA manufacturing market was valued at US$ 4.21 billion in 2024 and is projected to hit the market valuation of US$ 20.30 billion by 2033 at a CAGR of 19.1% during the forecast period 2025–2033.
US mRNA therapeutics CDMO market was valued at US$ 1.78 billion in 2024 and is projected to hit the market valuation of US$ 6.27 billion by 2033 at a CAGR of 15.01% during the forecast period 2025–2033.
Phosphoramidite market was valued at US$ 1.21 billion in 2024 and is projected to hit the market valuation of US$ 2.44 billion by 2033 at a CAGR of 8.1% during the forecast period 2025–2033.
The traumatic brain injury (TBI) market is expected to witness significant growth, with revenues projected to increase from USD 2.5 billion in 2024 to USD 4.7 billion by 2033, registering a strong CAGR of 7.2% during the forecast period.
Complementary and alternative medicine market was valued at US$ 193.36 billion in 2024 and is projected to hit the market valuation of US$ 1,282.70 billion by 2033 at a CAGR of 23.56% during the forecast period 2025–2033.
The glioblastoma multiforme treatment market is projected to grow from USD 3.0 billion in 2024 to USD 6.1 billion by 2033, registering a compound annual growth rate (CAGR) of 8.5% during the forecast period.
Amyotrophic lateral sclerosis treatment market is projected to grow from USD 724.5 million in 2024 to USD 1,234.5 million by 2033, expanding at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
The atopic dermatitis therapeutics market is poised for steady growth, with revenues projected to rise from USD 15.43 billion in 2024 to USD 29.5 billion by 2033. This reflects a compound annual growth rate (CAGR) of 7.5%.
Amyloidosis therapeutics market was valued at US$ 2.95 billion in 2024 and is projected to hit the market valuation of US$ 6.37 billion by 2033 at a CAGR of 9.20% during the forecast period 2025–2033.
Newborn eye imaging systems market was valued at US$ 1.86 billion in 2024 and is projected to hit the market valuation of US$ 3.09 billion by 2033 at a CAGR of 5.81% during the forecast period 2025–2033.
We use Cookies×
to improve your experience.